Docetaxel and atrasentan versus docetaxel and placebo for men with advanced castration-resistant prostate cancer (SWOG S0421): A randomised phase 3 trial

David I. Quinn, Catherine M. Tangen, Maha Hussain, Primo N. Lara, Amir Goldkorn, Carol M. Moinpour, Mark G. Garzotto, Philip C. Mack, Michael A. Carducci, J. Paul Monk, Przemyslaw W. Twardowski, Peter J. Van Veldhuizen, Neeraj Agarwal, Celestia S. Higano, Nicholas J. Vogelzang, Ian M. Thompson

Resultado de la investigación: Articlerevisión exhaustiva

130 Citas (Scopus)

Huella

Profundice en los temas de investigación de 'Docetaxel and atrasentan versus docetaxel and placebo for men with advanced castration-resistant prostate cancer (SWOG S0421): A randomised phase 3 trial'. En conjunto forman una huella única.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience

Immunology and Microbiology

Biochemistry, Genetics and Molecular Biology